Reassessment of the bifurcated aorto-iliac ENDURANT II/IIS stent graft, a mainstay of endovascular repair of abdominal aortic aneurysms. The opinion sets out the updated conditions for reimbursement, the anatomical indications retained (diameter above 5.5 cm in men, above 5 cm in women, or rapid growth) and the added benefit against the alternatives listed on the LPPR: sufficient benefit, added benefit level V.

The Society for Vascular Surgery publishes new clinical practice guidelines on the management of blunt thoracic aortic injury, superseding the 2011 recommendations. The document confirms TEVAR as the treatment of reference, introduces a new classification of injury grades and sets out the timing of intervention according to haemodynamic instability and anatomical grade.

SOFMER publishes good practice guidance setting out the use of medical compression in the management of venous thromboembolism. It specifies the choice of device, class and length, according to the clinical stage and the type of event, deep vein thrombosis or pulmonary embolism, the optimal duration, and coordination with anticoagulation to prevent post-thrombotic syndrome.

A systematic review and meta-analysis published in the Journal of Vascular Surgery (Anahita Dua, Boston) shows that transcatheter arterialisation of the deep veins achieves higher rates of limb salvage, amputation-free survival and wound healing than standard treatment in patients with chronic limb-threatening ischaemia and no conventional arterial revascularisation option.

Endospan announces FDA approval of the Nexus stent graft for treatment of the aortic arch, including chronic aortic dissection. The approval is supported by the one-year results of the TRIOMPHE IDE study. Nexus allows total endovascular treatment of the arch without deep hypothermia or cardiopulmonary bypass, in patients at high surgical risk.